Am I missing something here??
Unless I misread the announcement, the current FDA application approval is still imminent and with all the groundwork having been done in the U,S it’ll be ready to launch as soon as approval is granted. If the next product will not be worth the time and outlay then best to scrap it now.
Sure there were a few more shares than normal traded today but it only represents less than 1% of the stock.
Ann: Decision to Cease Development of US Respiratory Product, page-9
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
0.015(4.05%) |
Mkt cap ! $87.44M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.5¢ | 38.0¢ | $4.301K | 11.20K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 33000 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 20000 | 1 |
View Market Depth
| Last trade - 15.46pm 16/07/2025 (20 minute delay) ? |
| GSS (ASX) Chart |